Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:416-421

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banting, J. D.
Right arrow Articles by Adams, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banting, J. D.
Right arrow Articles by Adams, M. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1997;30:416.)
© 1997 American Heart Association, Inc.


Articles

Blunted Cardiovascular Growth Induction During Prolonged Nitric Oxide Synthase Blockade

James D. Banting; Karen E. Thompson; Peter Friberg; Michael A. Adams

From the Department of Pharmacology and Toxicology, Queen’s University, Kingston, Ontario, Canada (J.D.B., K.E.T., M.A.A.); and the Department of Physiology, Göteborg University, Göteborg, Sweden (P.F.).

Abstract The goal of the present study was to characterize the activation profile of the growth-related enzyme ornithine decarboxylase (ODC) in cardiovascular tissue during hypertension induced by chronic NO synthase blockade in relation to the development of structurally based changes in the heart and blood vessels. In previously instrumented conscious rats, mean arterial pressure and ODC activation were measured in cardiovascular tissue of rats treated with N{omega}-nitro-L-arginine methyl ester (L-NAME; 100 mg/kg per day PO) for 4 hours and 1, 6, and 12 days. After 12 days of L-NAME treatment alone or in combination with 3% L-ornithine, structurally based hindlimb resistance properties were assessed. A marginal activation of ODC in the left ventricle and aorta was seen at 4 hours but returned to control levels at 1, 6, and 12 days of L-NAME treatment. A slightly prolonged yet transient activation of ODC occurred in the mesenteric vascular bed. Structurally based hindlimb vascular resistance was enhanced by 15% at maximum vasoconstrictor tone, and no change in cardiac mass occurred with L-NAME treatment. L-NAME+3% L-ornithine treatment resulted in a similar level of structural upregulation compared with L-NAME treatment alone. In summary, 12 days of L-NAME treatment resulted in only a modest change in vascular resistance, and only at maximum constriction, and no cardiac hypertrophy despite the presence of marked hypertension. The results of the present study indicate that either (1) pressure alone is not a sufficient stimulus to induce cardiovascular growth processes or (2) L-NAME may be "nonspecifically" inhibiting cardiovascular growth processes.


Key Words: ornithine decarboxylase • hypertension • L-NAME • hypertrophy




This article has been cited by other articles:


Home page
HypertensionHome page
T. M. Hale, M. J. Shoichet, T. L. Bushfield, and M. A. Adams
Time Course of Vascular Structural Changes During and After Short-Term Antihypertensive Treatment
Hypertension, August 1, 2003; 42(2): 171 - 176.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Matsunaga, D. C. Warltier, D. W. Weihrauch, M. Moniz, J. Tessmer, and W. M. Chilian
Ischemia-Induced Coronary Collateral Growth Is Dependent on Vascular Endothelial Growth Factor and Nitric Oxide
Circulation, December 19, 2000; 102(25): 3098 - 3103.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Jolma, J. Kalliovalkama, J.-P. Tolvanen, P. Koobi, M. Kahonen, N. Hutri-Kahonen, X. Wu, and I. Porsti
High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1036 - H1043.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Kalliovalkama, P. Jolma, J.-P. Tolvanen, M. Kahonen, N. Hutri-Kahonen, X. Wu, P. Holm, and I. Porsti
Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism
Cardiovasc Res, June 1, 1999; 42(3): 773 - 782.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Zatz and C. Baylis
Chronic Nitric Oxide Inhibition Model Six Years On
Hypertension, December 1, 1998; 32(6): 958 - 964.
[Full Text] [PDF]